BioSyent Inc. (TSXV:RX)

Canada · Delayed Price · Currency is CAD

14.63

+0.22 (1.53%)

Apr 8, 2026, 12:15 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Business	43.05M	35.03M	31.59M	27.93M	28.62M
Pharmaceutical Business Growth	22.90%	10.89%	13.12%	-2.42%	28.15%
Total	43.05M	35.03M	31.59M	27.93M	28.62M
Total Growth	22.90%	10.89%	13.12%	-2.42%	28.15%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Canada	39.01M	33.83M	30.30M	27.02M	26.81M
Canada Growth	15.29%	11.66%	12.16%	0.77%	22.52%
Global	3.74M	929.98K	1.05M	683.58K	1.62M
Global Growth	301.73%	-11.24%	53.27%	-57.90%	621.21%
United States	308.07K	266.56K	241.81K	224.95K	183.99K
United States Growth	15.57%	10.23%	7.49%	22.26%	-18.19%
Total	43.05M	35.03M	31.59M	27.93M	28.62M
Total Growth	22.90%	10.89%	13.12%	-2.42%	28.15%

Source: S&P Global Market Intelligence.